{"id":"https://openalex.org/W4410125844","doi":"https://doi.org/10.1201/9781003498926-14","title":"Senolytics","display_name":"Senolytics","publication_year":2025,"publication_date":"2025-05-06","ids":{"openalex":"https://openalex.org/W4410125844","doi":"https://doi.org/10.1201/9781003498926-14"},"language":"en","primary_location":{"id":"doi:10.1201/9781003498926-14","doi":"https://doi.org/10.1201/9781003498926-14","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003498926-14","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advanced Drug Delivery Systems in Management of Chronic Obstructive Pulmonary Disease","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4410125676","display_name":"Advanced Drug Delivery Systems in Management of Chronic Obstructive Pulmonary Disease"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Abhilasha Ahlawat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abhilasha Ahlawat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064786744","display_name":"Neeta Solanki","orcid":"https://orcid.org/0000-0002-2689-7667","observed_orcids":["https://orcid.org/0000-0002-2689-7667","https://orcid.org/0000-0002-1341-5817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neeta Solanki","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035358791","display_name":"Sachin Kumar Singh","orcid":"https://orcid.org/0000-0003-3823-6572","observed_orcids":["https://orcid.org/0000-0003-3823-6572"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sachin Kumar Singh","raw_affiliation_strings":["School of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051181916","display_name":"Kamal Dua","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kamal Dua","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019466375","display_name":"Harish Dureja","orcid":"https://orcid.org/0000-0001-8336-1984","observed_orcids":["https://orcid.org/0000-0001-8336-1984"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harish Dureja","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1601757,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"190","last_page":"204"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10676","display_name":"Genetics, Aging, and Longevity in Model Organisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1302","display_name":"Aging"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/senolytics","display_name":"senolytics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.984000027179718},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.7350000143051147},{"id":"https://openalex.org/keywords/senescence-associated-secretory-phenotype","display_name":"senescence-associated secretory phenotype","score":0.8629999756813049},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.843999981880188},{"id":"https://openalex.org/keywords/quercetin","display_name":"quercetin","score":0.9580000042915344},{"id":"https://openalex.org/keywords/fisetin","display_name":"fisetin","score":0.9570000171661377},{"id":"https://openalex.org/keywords/navitoclax","display_name":"navitoclax","score":1.0},{"id":"https://openalex.org/keywords/lung-aging","display_name":"lung aging","score":0.7319999933242798},{"id":"https://openalex.org/keywords/emphysema","display_name":"emphysema","score":0.675000011920929},{"id":"https://openalex.org/keywords/fibrosis","display_name":"fibrosis","score":0.6710000038146973},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.6620000004768372},{"id":"https://openalex.org/keywords/telomere-dysfunction","display_name":"telomere dysfunction","score":0.800000011920929},{"id":"https://openalex.org/keywords/anti-apoptotic-pathways","display_name":"anti-apoptotic pathways","score":0.7689999938011169},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36413365602493286}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003498926-14","doi":"https://doi.org/10.1201/9781003498926-14","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003498926-14","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advanced Drug Delivery Systems in Management of Chronic Obstructive Pulmonary Disease","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3005426719","https://openalex.org/W3112768044","https://openalex.org/W4409864567","https://openalex.org/W7134843533","https://openalex.org/W3042236956","https://openalex.org/W4387982327","https://openalex.org/W4366525052","https://openalex.org/W4399691235","https://openalex.org/W3159582967","https://openalex.org/W3019562617"],"abstract_inverted_index":{"Senolytic":[0],"drugs":[1,7,211],"or":[2,108],"senotherapeutic":[3],"agents":[4,81,96,131,247,277,308],"are":[5,73,104,196,212,260],"the":[6,40,271,275,286,290,299],"that":[8,149,163,309],"can":[9,82,118],"selectively":[10],"remove":[11],"senescent":[12,59,115],"cells":[13,193],"(SC).":[14],"SC":[15,37,69,162],"resist":[16],"apoptosis":[17,220],"and":[18,23,46,52,102,171,187,205,221,240,292,305],"up-regulate":[19],"various":[20,216,306],"anti-apoptotic":[21,61],"pathways":[22],"generate":[24],"pro-inflammatory":[25],"senescence-associated":[26],"secretory":[27],"phenotypes":[28],"(SASP),":[29],"thus":[30],"allowing":[31],"them":[32],"to":[33,48,90,159,168,214,267,281],"survive.":[34],"With":[35],"aging,":[36],"accumulate":[38],"at":[39],"sites":[41],"of":[42,67,111,137,161,173,184,301,315],"multiple":[43],"chronic":[44],"disorders":[45,125],"lead":[47,158],"increased":[49],"morbidity,":[50],"mortality":[51],"health":[53],"expenditures.":[54],"Senolytics":[55,72],"temporarily":[56],"impair":[57],"these":[58,80],"cell":[60,65,116],"Pathways":[62],"(SCAPs),":[63],"causing":[64,199],"death":[66],"those":[68],"with":[70,245],"SASP.":[71],"considered":[74],"as":[75,79,86,98,127,139],"a":[76,120,135,140,234],"\u2018hit-and-run\u2019":[77],"approach,":[78],"be":[83,119,268,279,311],"administered":[84],"intermittently":[85],"they":[87],"take":[88],"weeks":[89],"reaccumulate.":[91],"The":[92],"first":[93],"generation":[94],"senolytic":[95,130,210,246,276,307],"such":[97,126],"dasatinib,":[99],"quercetin,":[100],"fisetin":[101],"navitoclax":[103],"identified":[105],"using":[106,274],"hypothesis":[107],"mechanism-based":[109],"approach":[110],"drug":[112],"discovery.":[113],"So,":[114],"targeting":[117,258],"treatment":[121,142,256],"option":[122],"for":[123,143,198],"aging-related":[124],"COPD.":[128,144,191,316],"Recently,":[129],"have":[132,164],"recently":[133],"drawn":[134],"lot":[136],"interest":[138],"potential":[141],"There":[145],"is":[146,151],"increasing":[147],"evidence":[148],"COPD":[150,195,238,244,283,304],"an":[152],"accelerated":[153],"lung":[154],"aging":[155],"disease,":[156],"which":[157,175],"aggregation":[160],"lost":[165],"their":[166],"ability":[167],"undergo":[169],"repair":[170],"secretion":[172],"SASPs,":[174],"causes":[176],"inflammation,":[177],"aberrant":[178],"repair,":[179],"resulting":[180],"in":[181,190,194,203,227,236,303,313],"fibrosis,":[182],"narrowing":[183],"airway,":[185],"emphysema":[186],"respiratory":[188],"failure":[189],"Senescent":[192],"responsible":[197],"oxidative":[200],"stress,":[201],"dysfunction":[202],"telomeres":[204],"damaging":[206],"DNA.":[207],"Various":[208,255],"proposed":[209],"known":[213],"activate":[215],"cell-signaling":[217],"molecules":[218,225],"promoting":[219,228],"inhibit":[222],"certain":[223],"signaling":[224],"involved":[226],"senescence":[229,259,273,302],"and,":[230],"thus,":[231],"may":[232,278,310],"play":[233],"role":[235,300],"improving":[237],"symptoms":[239],"reducing":[241],"comorbidities.":[242],"Targeting":[243,270],"has":[248],"shown":[249],"beneficial":[250],"effects":[251],"during":[252],"experimental":[253],"research.":[254],"approaches":[257],"under":[261],"development,":[262],"however,":[263],"clinical":[264,287],"trials":[265],"need":[266],"conducted.":[269],"cellular":[272],"transformative":[280],"counteract":[282],"progression":[284],"unless":[285],"studies":[288],"witness":[289],"effectiveness":[291],"low":[293],"toxicity.":[294],"This":[295],"chapter":[296],"focus":[297],"on":[298],"used":[312],"management":[314]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-05-07T00:00:00"}